SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0000950170-24-042273
Filing Date
2024-04-05
Accepted
2024-04-05 16:14:07
Documents
13
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A sctl-20231231.htm   iXBRL 10-K/A 737835
2 EX-31.3 sctl-ex31_3.htm EX-31.3 7062
3 EX-31.4 sctl-ex31_4.htm EX-31.4 6895
  Complete submission text file 0000950170-24-042273.txt   3118038

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT sctl-20231231.xsd EX-101.SCH 1555804
16 EXTRACTED XBRL INSTANCE DOCUMENT sctl-20231231_htm.xml XML 10309
Mailing Address 1 E. UWCHLAN AVE, SUITE 112 EXTON PA 19341
Business Address 1 E. UWCHLAN AVE, SUITE 112 EXTON PA 19341 770-534-8239
Societal CDMO, Inc. (Filer) CIK: 0001588972 (see all company filings)

IRS No.: 261523233 | State of Incorp.: PA | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-36329 | Film No.: 24826672
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)